Cutis Laxa isn't one condition — it's caused by 9+ genes across dominant, recessive, and syndromic forms, each carrying different risks beyond the skin.
Learn about Spinal Muscular Atrophy genetics, carrier screening importance in the UAE, and the true cost of gene therapy treatments like Zolgensma and Spinraza.
UAE's 2025 mandate: premarital genetic screening for Emirati couples. Tests 570+ genes, identifies at-risk couples (8%), enables informed family planning via counseling & IVF/PGT-M.
A comprehensive clinical analysis of ASD genetics, exploring high-confidence genes, de novo mutations, and the role of NGS-based testing in personalized medical management for UAE families.
A 190-gene hereditary cancer panel offers UAE patients a complete risk profile, capturing unique genetic factors and enabling personalized prevention strategies.
DMD carrier screening in UAE uses advanced 79-exon MLPA and NGS testing to identify female carriers, guide family planning, and enable early intervention for at-risk children.
UAE’s BRCA1/2 landscape reveals unique variants, earlier cancer onset, and consanguinity-driven risks, shaping precision prevention and personalized genetic care.
The Infertility Panel Genetic Test in the UAE uncovers hidden mutations, recurrent miscarriage risks, and guides IVF with precision medicine for informed reproductive decisions.
Fragile X syndrome, caused by FMR1 gene mutation, is the most common inherited intellectual disability. Early genetic testing in the UAE empowers families with proactive care and informed decisions.
Our team will contact you within 15 minutes
Saving your details...
